Showing results (1351-1360 of 9,007) with videos related to
Sort By:
Pageof 901
European Journal of Clinical Pharmacology|May 8, 2012
Anti-androgen prescribing patterns, patient treatment adherence and influencing factors; results from the nationwide PCBaSe SwedenB Grundmark, H Garmo, B Zethelius, et al.European Journal of Clinical Pharmacology|June 1, 2012
Drug-induced life-threatening potassium disturbances detected by a pharmacovigilance program from laboratory signalsElena Ramírez, Tomás Rossignoli, Armando J Campos, et al.European Journal of Clinical Pharmacology|June 1, 2012
The effect of operational stressors on ibuprofen pharmacokineticsCathy Boscarino, Andrea N Edginton, Henry Peng, et al.European Journal of Clinical Pharmacology|June 5, 2012
Prediction of the tacrolimus population pharmacokinetic parameters according to CYP3A5 genotype and clinical factors using NONMEM in adult kidney transplant recipientsNayoung Han, Hwi-yeol Yun, Jin-yi Hong, et al.European Journal of Clinical Pharmacology|December 1, 2012
Bioequivalence between generic tacrolimus products marketed in Spain by adjusted indirect comparisonMarta Herranz, Susana Morales-Alcelay, Ma Teresa Corredera-Hernández, et al.European Journal of Clinical Pharmacology|November 27, 2012
A review of the potential protective effects of pentoxifylline against drug-induced nephrotoxicityZahra Nasiri-Toosi, Simin Dashti-Khavidaki, Hossein Khalili, et al.European Journal of Clinical Pharmacology|December 4, 2013
Drug-induced agranulocytosis in the Berlin case-control surveillance studyMatthias Huber, Frank Andersohn, Elisabeth Bronder, et al.European Journal of Clinical Pharmacology|December 11, 2013
The quality of outpatient antimicrobial prescribing: a comparison between two areas of northern and southern EuropeSara Malo, Lars Bjerrum, Cristina Feja, et al.European Journal of Clinical Pharmacology|November 27, 2013
Persistence of antihypertensive drug use in German primary care: a follow-up study based on pharmacy claims dataThomas Grimmsmann, Wolfgang HimmelEuropean Journal of Clinical Pharmacology|October 1, 2013
The impact of CYP2D6 polymorphisms on the pharmacokinetics of codeine and its metabolites in Mongolian Chinese subjectsXiujun Wu, Li Yuan, Jinliang Zuo, et al.Pageof 901